AbCellera loses Chief Business Officer Neil Berkley effective June 29, 2022

AbCellera Biologics Inc.

Neil Berkley departed as Chief Business Officer effective June 29, 2022; not due to any disagreement with the Company.
Berkley qualifies for severance benefits under the Company's Executive Severance Plan (terms previously disclosed in proxy statement).
No successor named in the filing; departure is effective immediately.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Neil Berkley

Chief Business Officer

ABCL · AbCellera Biologics Inc.

Effective: 2022-06-29
Filed: July 6, 2022, 7:59 PM ET

Effective June 29, 2022, Neil Berkley is no longer the Chief Business Officer of AbCellera Biologics Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Neil Berkley departed as Chief Business Officer at AbCellera Biologics Inc..

Action: departed
Role: Chief Business Officer

Exact text from the filing

Effective June 29, 2022, Neil Berkley is no longer the Chief Business Officer of AbCellera Biologics Inc.

View on SEC.gov

AbCellera Biologics Inc. filing history →

Source: SEC EDGAR

accession 0001564590-22-025392

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.